What is the commonly mentioned Hepatitis B virus?

We often hear about hepatitis B virus (HBV) in our daily life. There are relatively many patients with hepatitis B virus (HBV) in our country, accounting for about 30% of the total number of hepatitis B patients. There are two types of small triple positive. One is that it gradually gets better, which means that the virus replication decreases or becomes static. The other is that the virus will continue to replicate, causing the disease to worsen.

What is Hepatitis B virus

The so-called "small three positive" of hepatitis B means that among the five indicators of the "two pairs and a half" examination of hepatitis B, the surface antigen (HBsAg), E antibody (HBeAb) and core antibody (HBcAb) are all positive. The two-pair-and-a-half test report for hepatitis B shows HBsAg(+), HBeAb(+), and anti-HBc(+). The appearance of "small three positives" indicates acute or chronic hepatitis B and viral replication in the body, which is a state of hepatitis B virus replication. There are a large number of hepatitis B patients in my country, accounting for about 30% of the total number of hepatitis B patients. Currently, superoxide cell therapy is commonly used in clinical treatment of hepatitis B virus (HBV). Small triple positive is usually transformed from "big triple positive", which means that the human body has developed a certain degree of immunity against the E antigen.

There are two situations in which hepatitis B "small three positive" exists

One is that the replication of the hepatitis B virus is reduced or tends to be static after autoimmune regulation or antiviral treatment, which is a good phenomenon; the other is the result of the mutation of the hepatitis B virus. Although it is "small three positive", the virus replication still continues and the condition worsens, which is a bad phenomenon. Therefore, patients with "small three positive" must be treated differently, and whether they should be treated depends on the specific circumstances.

Theoretically, all patients with "small three positive" should be treated. No matter what form the existence of hepatitis B "small three positive" is a potential threat to human health, and there is no doubt that they must be eliminated in a timely and thorough manner. Some patients with "small three positive" have long-term fluctuations in liver function, but do not receive correct treatment, which causes the disease to gradually develop and eventually develop into cirrhosis.

When encountering the following situations, patients with "small three positive" need timely treatment.

1. There are obvious symptoms, such as fatigue, loss of appetite, abdominal distension, discomfort in the liver area, etc.

2. Repeated fluctuations in liver function: increased transaminase and serum bilirubin, decreased albumin, etc.

3. Those whose hepatitis B virus deoxyribonucleic acid (HBVDNA) test is positive. The principle of treatment is a combination of restoring liver function, fighting viruses and preventing liver fibrosis.